The Board of Directors (the “Board”) of Omnicane Limited (the “Company”) hereby informs its shareholders, its noteholders, the noteholders’ representative and the public in general that in course of its financial re-structuring exercise currently being worked on, notes pursuant to its programme memorandum, pricing supplements for Series 2, 3 and 4 and listing particulars dated 26 May 2016, 08 June 2016 and 30 September 2016 respectively (the “Notes”) reaching maturity on 8 June 2021 may be subject to early repayment.
Shareholders of Omnicane Limited, noteholders and the investing public will be kept informed of further developments and are therefore advised to exercise caution when dealing in the shares of Omnicane Limited.
By Order of the Board
Omnicane Management and Consultancy Limited
Managers & Secretaries